122 related articles for article (PubMed ID: 24566015)
1. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
[TBL] [Abstract][Full Text] [Related]
2. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality : A Prospective Cohort Study.
Sheikh M; Mukeriya A; Shangina O; Brennan P; Zaridze D
Ann Intern Med; 2021 Sep; 174(9):1232-1239. PubMed ID: 34310171
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative.
Snee M; Cheeseman S; Thompson M; Riaz M; Sopwith W; Lacoin L; Chaib C; Daumont MJ; Penrod JR; Hall G
BMJ Open; 2021 Sep; 11(9):e046396. PubMed ID: 34526333
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
Provencio M; Carcereny E; López Castro R; Calvo V; Rodríguez Abreu D; Cobo M; Ortega AL; Bernabé R; Guirado M; Massutí B; Del Barco-Morillo E; Bosch-Barrera J; Camps C; Carroll R; Rault C; Chaib C; Penrod J; Vo L; Ralphs E; Daumont MJ
Transl Lung Cancer Res; 2023 Oct; 12(10):2113-2128. PubMed ID: 38025806
[TBL] [Abstract][Full Text] [Related]
5. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
[TBL] [Abstract][Full Text] [Related]
6. [Survival analysis of 1,742 patients with stage IV non-small cell lung cancer].
Peng H; Ma M; Han B
Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):362-6. PubMed ID: 21496437
[TBL] [Abstract][Full Text] [Related]
7. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
Fares AF; Li Y; Jiang M; Brown MC; Lam ACL; Aggarwal R; Schmid S; Leighl NB; Shepherd FA; Wang Z; Diao N; Wenzlaff AS; Xie J; Kohno T; Caporaso NE; Harris C; Ma H; Barnett MJ; Leal LF; Fernandez-Tardon G; Pérez-Ríos M; Davies MPA; Taylor F; Schöttker B; Brennan P; Zaridze D; Holcatova I; Lissowska J; Świątkowska B; Mates D; Savic M; Brenner H; Andrew A; Cox A; Field JK; Ruano-Ravina A; Shete SS; Tardon A; Wang Y; Le Marchand L; Reis RM; Schabath MB; Chen C; Shen H; Ryan BM; Landi MT; Shiraishi K; Zhang J; Schwartz AG; Tsao MS; Christiani DC; Yang P; Hung RJ; Xu W; Liu G
Lancet Public Health; 2023 Sep; 8(9):e691-e700. PubMed ID: 37633678
[TBL] [Abstract][Full Text] [Related]
8. Survival and safety analysis of COVID-19 vaccine in Chinese patients with non-small cell lung cancer.
Xu W; Zhao J; Luan F; Zhang Z; Liu L; Zhao H; Feng B; Fu G
Cancer Med; 2024 Apr; 13(8):e7032. PubMed ID: 38651178
[TBL] [Abstract][Full Text] [Related]
9. Identification of patient characteristics associated with survival benefit from metformin treatment in patients with stage I non-small cell lung cancer.
Elkin PL; Mullin S; Tetewsky S; Resendez SD; McCray W; Barbi J; Yendamuri S
J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1318-1326.e3. PubMed ID: 35469597
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Diagnoses, Survival, and Costs of Oncological Medical Treatment for Non-Small-Cell Lung Cancer over 20 Years in Osona, Catalonia.
Parera Roig M; Colomé DC; Colomer GB; Sardo EG; Tournour MA; Fernández SG; Ominetti AI; Juvanteny EP; Polo JLM; Jobal DB; Espejo-Herrera N
Curr Oncol; 2024 Apr; 31(4):2145-2157. PubMed ID: 38668062
[TBL] [Abstract][Full Text] [Related]
11. Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
Gupta A; Nguyen P; Kain D; Robinson AG; Kulkarni AA; Johnson DH; Presley CJ; Blaes AH; Rocque GB; Ganguli I; Booth CM; Hanna TP
JAMA Netw Open; 2024 Apr; 7(4):e244278. PubMed ID: 38587847
[TBL] [Abstract][Full Text] [Related]
12. Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
Meldgaard P; Kristensen M; Conte S; Kaae Andersen K; Jovanovic A; Meldgaard E
Acta Oncol; 2023 Dec; 62(12):1672-1679. PubMed ID: 37699061
[TBL] [Abstract][Full Text] [Related]
13. An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients.
Alghamdi HI; Alshehri AF; Farhat GN
J Epidemiol Glob Health; 2018 Mar; 7 Suppl 1(Suppl 1):S1-S6. PubMed ID: 29801587
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Howlader N; Forjaz G; Mooradian MJ; Meza R; Kong CY; Cronin KA; Mariotto AB; Lowy DR; Feuer EJ
N Engl J Med; 2020 Aug; 383(7):640-649. PubMed ID: 32786189
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer survival and sex-specific patterns in Portugal: A population-based analysis.
Guerreiro T; Forjaz G; Antunes L; Bastos J; Mayer A; Aguiar P; Araújo A; Nunes C
Pulmonology; 2023 Dec; 29 Suppl 4():S70-S79. PubMed ID: 34642125
[TBL] [Abstract][Full Text] [Related]
16. The reliability and validity of lung cancer and melanoma clinical quality survival measures.
Pendl-Robinson E; Calkins KL; Simon SE; Barrett K; Poznyak D
Health Serv Res; 2023 Oct; 58(5):1131-1140. PubMed ID: 37669902
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns in stage III non‑small‑cell lung cancer patients: a population‑based study using German cancer registry data.
Bedir A; Mehrotra S; Gnüchtel J; Vordermark D; Medenwald D
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15489-15497. PubMed ID: 37648808
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment Characteristics of Operated Lung Cancer Patients.
Arak H; Eronat O; Dogan I; Aydin ES; Aytekin A
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1271-1277. PubMed ID: 37926880
[TBL] [Abstract][Full Text] [Related]
19. Disease prognosis and therapeutic strategies in patients with advanced non-small cell lung cancer (NSCLC): a 6-year epidemiological study between 2015-2021.
Alamri S; Badah MZ; Zorgi S; Alenazi R; Alshanbari HM; Ali MAM; Murished G; Awadalla ME; Alshihre A; Alghareeb WA; Alosaimi B
Transl Cancer Res; 2024 Feb; 13(2):762-770. PubMed ID: 38482430
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre.
Mosteiro M; Azuara D; Villatoro S; Alay A; Gausachs M; Varela M; Baixeras N; Pijuan L; Ajenjo-Bauza M; Lopez-Doriga A; Teulé Á; Solanes A; Palmero R; Brenes J; Jové M; Padrones S; Moreno V; Cordero D; Matías-Guiu X; Lázaro C; Nadal E
ESMO Open; 2023 Dec; 8(6):102197. PubMed ID: 38070435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
